Hit in the solar plexus for emergency rooms | March 26, 2014 | Cardiovascular Business | Interventional CardiologyThe New York Times reports that nitroglycerine, the go-to drug in emergency rooms when physicians suspect an MI, may face intermittent shortages, according to its sole supplier.Nitroglycerine, a staple of emergency rooms, is in short supply Subscribe to Cardiovascular Business NewsEmail Address * Related ContentFirst patients treated for TRIUMPH trial focused on new TTVR techMirvat Alasnag honored with Woman Cardiologist of the Year awardAbbott now enrolling patients for new research on Cephea mitral valve replacement deviceFDA confirms Class I recall for certain Impella heart pump controllersStrokes after TAVR remain a problem: Key insights from new registry dataFDA approves transcatheter device for treating PVL after heart surgery for first timeAround the webHealth Exec An inside look at the changing culture of the FDAHealth Exec FDA balances faster AI adoption with safety as healthcare technology advancesRadiology Business Maryland mammography law turns incidental cardiac findings into a new screening opportunitySubscribe to Cardiovascular Business NewsEmail Address * Subscribe to Cardiovascular Business NewsEmail Address *